An ICC panel in New York is hearing a US$1.5 billion claim against US pharmaceuticals group Bristol Myers Squibb over the supply of a cancer therapy drug that was blocked by Chinese regulators.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Subscribe now
Already have access? Login below
"claim" - Google News
October 16, 2021 at 01:07AM
https://ift.tt/3j6ZDDd
Bristol Myers faces billion-dollar claim over cancer drug - GAR
"claim" - Google News
https://ift.tt/2FrzzOU
https://ift.tt/2VZxqTS
Bagikan Berita Ini
0 Response to "Bristol Myers faces billion-dollar claim over cancer drug - GAR"
Post a Comment